PERSPECTA

News from every angle

← Back to headlines

Telix Pharmaceuticals Misses EPS and Revenue Estimates

Telix Pharmaceuticals reported a GAAP EPS of -$2.11, missing estimates by $2.14, with revenue of $803.8 million also falling short by $22.79 million.

18 Feb, 13:45 — 19 Feb, 22:52

PostShare

Perspective Analysis

Comparing sources…